SCHEMBL5796609

SCHEMBL5796609

Cc1c(-c2ccccc2)[c]ccc1-c1ccccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.39
LMNA P02545 6/20 0.39
HIF1A Q16665 3/20 0.39
CCR1 P32246 2/20 0.39
CCR5 P51681 2/20 0.39
CCR8 P51685 2/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
METAP1 P53582 1/20 0.39
BLM P54132 1/20 0.39
DOHH Q9BU89 1/20 0.39
P4HTM Q9NXG6 1/20 0.39
TGFBR1 P36897 1/20 0.39
CYP2A6 P11509 1/20 0.38
SMN1; SMN2 Q16637 8/20 0.36
NPC1 O15118 6/20 0.36
TP53 P04637 6/20 0.36
RAB9A P51151 5/20 0.36
PKM P14618 3/20 0.36
NPY5R Q15761 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7571214 0.79 KDM4E (0.43) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL1033552 0.76 KDM4E (0.48) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL7570520 0.75 TGFBR1 (0.42) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL5797476 0.75 CYP2A6 (0.44) CYP1A2CYP2A6NPY5RALDH1A1
SCHEMBL13834138 0.75 PDCD1 (0.52) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL14782863 0.73 KDM4E (0.41) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL7569351 0.72 TGFBR1 (0.45) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL4775110 0.72 RAB9A (0.37) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL19592547 0.72 KDM4E (0.56) KDM4ELMNAHIF1ACCR1CCR5
SCHEMBL21742644 0.71 TGFBR1 (0.47) KDM4ELMNAHIF1ACCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006033995-A2 THIAZOLIDIN-4-ONES HAVING ANTI-HEPATITIS B ACTIVITY VALEANT RESEARCH AND DEVELOPMENT (US) 2006-03-30 WO disclosed